Abstract | BACKGROUND/AIMS: Rapid removal of plasma amyloid-β (Aβ) by blood purification may serve as a peripheral Aβ sink from the brain for Alzheimer's disease therapy. We investigated the reduction of plasma Aβ during hemodialysis and cognitive states. METHODS: Aβ concentrations and Mini-Mental State Examinations (MMSE) were investigated in 37 hemodialysis patients (68.9 ± 4.1 years). RESULTS: The dialyzers effectively removed Aβ(1-40) and Aβ(1-42), 63.9 ± 14.4 and 51.6 ± 17.0% at 4 h dialysis, resulting in the reduction of Aβs in whole-body circulation by 51.1 ± 8.9 and 32.7 ± 12.0%, respectively. Although the plasma Aβs before dialysis (750.8 ± 171.3 pg/ml for Aβ(1-40)) were higher than those reported for Alzheimer's disease patients, the cognitive states of hemodialysis patients were relatively normal, especially of longer dialysis vintages. CONCLUSIONS: Dialyzers effectively reduced Aβs in whole-body circulation. Repeated rapid decrease of plasma Aβs might maintain cognitive state.
|
Authors | N Kitaguchi, K Kawaguchi, S Nakai, K Murakami, S Ito, H Hoshino, H Hori, A Ohashi, Y Shimano, N Suzuki, Y Yuzawa, T Mutoh, S Sugiyama |
Journal | Blood purification
(Blood Purif)
Vol. 32
Issue 1
Pg. 57-62
( 2011)
ISSN: 1421-9735 [Electronic] Switzerland |
PMID | 21346337
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 S. Karger AG, Basel. |
Chemical References |
- Amyloid beta-Peptides
- Peptide Fragments
- amyloid beta-protein (1-40)
- amyloid beta-protein (1-42)
|
Topics |
- Aged
- Alzheimer Disease
(blood, pathology, physiopathology, psychology, therapy)
- Amyloid beta-Peptides
(blood, isolation & purification)
- Brain
(metabolism, pathology, physiopathology)
- Cognition
- Enzyme-Linked Immunosorbent Assay
- Humans
- Male
- Middle Aged
- Neuropsychological Tests
- Peptide Fragments
(blood, isolation & purification)
- Renal Dialysis
(statistics & numerical data)
|